BSN.DEBSN.DEXETRA
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank82
3Y CAGR+18.8%
5Y CAGR-6.2%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+18.8%/yr
vs +12.1%/yr prior
5Y CAGR
-6.2%/yr
Recent acceleration
Acceleration
+6.6pp
Accelerating
Percentile
P82
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 12.89% |
| Q2 2025 | -7.02% |
| Q4 2024 | 18.05% |
| Q2 2024 | -6.82% |
| Q4 2023 | 23.60% |
| Q2 2023 | -3.26% |
| Q4 2022 | 18.71% |
| Q2 2022 | -9.88% |
| Q4 2021 | 3.61% |
| Q2 2021 | 0.00% |
| Q4 2020 | 5.73% |
| Q2 2020 | -13.74% |
| Q4 2019 | 7.69% |
| Q2 2019 | -2.87% |
| Q4 2018 | 6.75% |
| Q2 2018 | -9.44% |
| Q4 2017 | 11.11% |
| Q2 2017 | -8.99% |
| Q4 2016 | 14.84% |
| Q2 2016 | -6.63% |
| Q4 2015 | 17.73% |
| Q2 2015 | 1.44% |
| Q4 2014 | 4.51% |
| Q2 2014 | -2.21% |
| Q4 2013 | -2.16% |
| Q2 2013 | 5.30% |
| Q4 2012 | 5.60% |
| Q2 2012 | 7.30% |
| Q4 2011 | 0.00% |
| Q2 2011 | 11.48% |
| Q4 2010 | 0.00% |
| Q2 2010 | 1.46% |
| Q4 2009 | 0.00% |
| Q2 2009 | 4.04% |
| Q4 2008 | 0.00% |
| Q2 2008 | 63.64% |
| Q4 2007 | 0.00% |
| Q2 2007 | -36.11% |
| Q4 2006 | 202.50% |
| Q2 2006 | -65.31% |